MBS Review Taskforce meeting outcomes, 30 November 2017

On 30 November 2017, the Medicare Benefits Schedule (MBS) Review Taskforce (the Taskforce) held its 25th meeting. The following is a summary of the outcome arising from the meeting.

Page last updated: 13 July 2018

PDF version: MBS Review Taskforce meeting outcomes, 30 November 2017 (PDF 17 KB)

Orthopaedic Clinical Committee report for public consultation

The Taskforce endorsed the release of the report of the Orthopaedic Clinical Committee for public consultation, subject to minor changes.

Second Diagnostic Medicine Clinical Committee report for public consultation

The Taskforce endorsed the release of the Second Report for Diagnostic Medicine Clinical Committee for public consultation.

Renal Medicine Clinical Committee report for endorsement

The Taskforce endorsed the final Renal Medicine Clinical Committee’s report recommendations for Government.

Spinal Surgery Clinical Committee report

The Taskforce approved the recommendations of the Spinal Surgery Clinical Committee to Government.

Establishment of the Breast Cancer Surgery and Reconstruction Working Group

The Taskforce approved for the work arising from the independent Breast Cancer Surgery & Reconstruction Working Group to be considered by the Plastic and Reconstructive Surgery Clinical Committee once it is established.

Dermatology, Allergy, and Immunology Clinical Committee report

The Taskforce approved the recommendations of the Dermatology Allergy & Immunology Report to Government.

Pathology Blood Products Report for public consultation

The Taskforce endorsed the release of the report of the Pathology Clinical Committee – Blood Products for public consultation, subject to minor changes.